These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16539663)

  • 1. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
    Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
    J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
    Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
    J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.
    Counts SE; Nadeem M; Wuu J; Ginsberg SD; Saragovi HU; Mufson EJ
    Ann Neurol; 2004 Oct; 56(4):520-31. PubMed ID: 15455399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
    Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
    Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.
    Mufson EJ; Counts SE; Fahnestock M; Ginsberg SD
    Curr Alzheimer Res; 2007 Sep; 4(4):340-50. PubMed ID: 17908035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
    Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
    Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.
    Counts SE; Mufson EJ
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):263-72. PubMed ID: 15835262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
    Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.
    Mufson EJ; Ma SY; Cochran EJ; Bennett DA; Beckett LA; Jaffar S; Saragovi HU; Kordower JH
    J Comp Neurol; 2000 Nov; 427(1):19-30. PubMed ID: 11042589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease.
    Chu Y; Cochran EJ; Bennett DA; Mufson EJ; Kordower JH
    J Comp Neurol; 2001 Aug; 437(3):296-307. PubMed ID: 11494257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease.
    Mufson EJ; Li JM; Sobreviela T; Kordower JH
    Neuroreport; 1996 Dec; 8(1):25-9. PubMed ID: 9051746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration.
    Venero JL; Knüsel B; Beck KD; Hefti F
    Neuroscience; 1994 Apr; 59(4):797-815. PubMed ID: 8058122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Vana L; Kanaan NM; Ugwu IC; Wuu J; Mufson EJ; Binder LI
    Am J Pathol; 2011 Nov; 179(5):2533-50. PubMed ID: 21945902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.
    Mufson EJ; Ginsberg SD; Ikonomovic MD; DeKosky ST
    J Chem Neuroanat; 2003 Dec; 26(4):233-42. PubMed ID: 14729126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
    Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Che S; Counts SE; Mufson EJ
    J Neurochem; 2006 Mar; 96(5):1401-8. PubMed ID: 16478530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
    Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
    J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.